Cardiac disease in chronic uremia: management (Q41547197)

3 October 2017

1 reference

title

Cardiac disease in chronic uremia: management (English)

1 reference

3 October 2017

1 reference

1 reference

Venkatesan J

1

1 reference

3 October 2017

Henrich WL

series ordinal

2

1 reference

3 October 2017

publication date

1 July 1997

1 reference

Advances in Chronic Kidney Disease

3 October 2017

published in

1 reference

3 October 2017

volume

4

1 reference

3 October 2017

issue

3

1 reference

3 October 2017

page(s)

249-266

1 reference

The Natural History of Congestive Heart Failure: The Framingham Study

3 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2897%2970033-5

7 January 2021

Congestive heart failure in dialysis patients: prevalence, incidence, prognosis and risk factors.

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2897%2970033-5

7 January 2021

Clinical and echocardiographic disease in patients starting end-stage renal disease therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2897%2970033-5

7 January 2021

Outcome and risk factors for left ventricular disorders in chronic uraemia

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2897%2970033-5

7 January 2021

Effect of hemodialysis on left ventricular performance. Analysis of echocardiographic subsets

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2897%2970033-5

7 January 2021

Increased ionized calcium and left ventricular contractility during hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2897%2970033-5

7 January 2021

Acute effects of dialysis on myocardial contractility: influence of cardiac status and calcium/potassium ratio

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2897%2970033-5

7 January 2021

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2897%2970033-5

7 January 2021

Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2897%2970033-5

7 January 2021

Relative efficacy of vasodilator therapy in chronic congestive heart failure. Implications of randomized trials.

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2897%2970033-5

7 January 2021

To what extent do congestive heart failure patients in sinus rhythm benefit from digoxin therapy? A systematic overview and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2897%2970033-5

7 January 2021

Beta-blockers after myocardial infarction: influence of first-year clinical course on long-term effectiveness.

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2897%2970033-5

7 January 2021

Beneficial effects of long-term beta-blockade in congestive cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2897%2970033-5

7 January 2021

Improvement in symptoms and exercise tolerance by metoprolol in patients with dilated cardiomyopathy: a double-blind, randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2897%2970033-5

7 January 2021

Effect of xamoterol (ICI 118587), a new beta1 adrenoceptor partial agonist, on resting haemodynamic variables and exercise tolerance in patients with left ventricular dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2897%2970033-5

7 January 2021

Effect of chronic renal failure on heart. Role of secondary hyperparathyroidism

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2897%2970033-5

7 January 2021

Effect of parathyroidectomy on left-ventricular function in haemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2897%2970033-5

7 January 2021

Uremic Cardiomyopathy: Potential Role of Vitamin D and Parathyroid Hormone

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2897%2970033-5

7 January 2021

Is parathormone a cardiac toxin in uremia?

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2897%2970033-5

7 January 2021

Parathyroid hormone suppression by intravenous 1,25-dihydroxyvitamin D. A role for increased sensitivity to calcium

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2897%2970033-5

7 January 2021

Oral calcitriol and calcium: efficient therapy for uremic hyperparathyroidism

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2897%2970033-5

7 January 2021

Heart Failure as a Complication of Hemodialysis Arteriovenous Fistula

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2897%2970033-5

7 January 2021

High-output cardiac failure due to excessive shunting in a hemodialysis access fistula: an easily overlooked diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2897%2970033-5

7 January 2021

The impact of anemia on cardiomyopathy, morbidity, and and mortality in end-stage renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2897%2970033-5

7 January 2021

Evidence-based recommendations for the clinical use of recombinant human erythropoietin

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2897%2970033-5

7 January 2021

Vascular changes in hemodialysis patients in response to recombinant human erythropoietin

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2897%2970033-5

7 January 2021

Beneficial effects of erythropoietin on haematological parameters, aerobic capacity, and body fluid composition in patients on haemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2897%2970033-5

7 January 2021

Correction of renal anaemia by recombinant human erythropoietin: effects on myocardial function

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2897%2970033-5

7 January 2021

Long-term cardiorespiratory effects of amelioration of renal anaemia by erythropoietin

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2897%2970033-5

7 January 2021

Accelerated Atherosclerosis in Chronic-Dialysis Patients – Another Look

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2897%2970033-5

7 January 2021

Ischemic heart disease in patients with uremia undergoing maintenance hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2897%2970033-5

7 January 2021

Accelerated atherosclerosis in long-term dialysis and renal-transplant patients: fact or fiction?

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2897%2970033-5

7 January 2021

Disabling angina pectoris with normal coronary arteries in patients undergoing long-term hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2897%2970033-5

7 January 2021

Dialysis-associated ischemic heart disease: insights from coronary angiography

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2897%2970033-5

7 January 2021

Beneficial Six-Year Outcome of Smoking Cessation in Older Men and Women with Coronary Artery Disease

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2897%2970033-5

7 January 2021

The role of hypertension in hemodialysis-associated atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2897%2970033-5

7 January 2021

Relationship of coronary risk factors to hemodialysis-associated ischemic heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2897%2970033-5

7 January 2021

Left ventricular hypertrophy by electrocardiogram. Prevalence, incidence, and mortality in the Framingham study

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2897%2970033-5

7 January 2021

Systolic versus diastolic blood pressure and risk of coronary heart disease. The Framingham study

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2897%2970033-5

7 January 2021

Cardiac calcification in uremia. A clinical, biochemical and pathologic study

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2897%2970033-5

7 January 2021

Management of hyperlipidemia of kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2897%2970033-5

7 January 2021

Epidemiology as a guide to clinical decisions. The association between triglyceride and coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2897%2970033-5

7 January 2021

Atherogenic lipids and lipoproteins in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2897%2970033-5

7 January 2021

Effects of dietary fish oil on serum lipids and blood coagulation in peritoneal dialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2897%2970033-5

7 January 2021

Effects of fish oil rich in eicosapentaenoic acid on serum lipid in hyperlipidemic hemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2897%2970033-5

7 January 2021

Recombinant human erythropoietin in anemic patients with end-stage renal disease. Results of a phase III multicenter clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2897%2970033-5

7 January 2021

Hypopnea associated with acetate hemodialysis: carbon dioxide-flow-dependent ventilation

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2897%2970033-5

7 January 2021

Hypoxemia during hemodialysis: a critical review of the facts

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2897%2970033-5

7 January 2021

A comparison of coronary angioplasty and coronary artery bypass grafting outcomes in chronic dialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2897%2970033-5

7 January 2021

Increased morbidity after coronary angioplasty in patients on chronic hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2897%2970033-5

7 January 2021

Results of coronary artery bypass grafting in end-stage renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2897%2970033-5

7 January 2021

Coronary artery bypass surgery in patients on maintenance dialysis: long-term survival

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2897%2970033-5

7 January 2021

Coronary artery surgery study (CASS): a randomized trial of coronary artery bypass surgery. Survival data

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2897%2970033-5

7 January 2021

A randomized trial of coronary artery bypass surgery. Survival of patients with a low ejection fraction

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2897%2970033-5

7 January 2021

Coronary revascularisation in insulin-dependent diabetic patients with chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2897%2970033-5

7 January 2021

Continuous ambulatory peritoneal dialysis for patients with severe left ventricular systolic dysfunction and end-stage renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2897%2970033-5

7 January 2021

Different dialytic modalities in the management of hypertension in uremic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2897%2970033-5

7 January 2021

Changes in left ventricular hypertrophy and function in hypertensive patients started on continuous ambulatory peritoneal dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2897%2970033-5

7 January 2021

Hemodynamic changes during acetate and bicarbonate hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2897%2970033-5

7 January 2021

Delayed hypotensive response to dialysis in hypertensive patients with end-stage renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2897%2970033-5

7 January 2021

Effects of hemodialysis and saline loading on body fluid compartments, plasma renin activity and blood pressure in patients on chronic hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2897%2970033-5

7 January 2021

Blood pressure response to changes in serum ionized calcium during hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2897%2970033-5

7 January 2021

Pathophysiology and management of hypertension in continuous ambulatory peritoneal dialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2897%2970033-5

7 January 2021

Permanent loss of ultrafiltration capacity of the peritoneum in long-term peritoneal dialysis: an epidemiological study

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2897%2970033-5

7 January 2021

Sodium homeostasis in chronic renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2897%2970033-5

7 January 2021

Long-term effects of nifedipine on carbohydrate and lipid metabolism in hypertensive hemodialyzed patients

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2897%2970033-5

7 January 2021

Glucose tolerance and secretion and clearance of insulin during long term felodipine treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2897%2970033-5

7 January 2021

Verapamil protects against progression of experimental chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2897%2970033-5

7 January 2021

Antihypertensive and hypouricaemic effects of nitrendipine in chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2897%2970033-5

7 January 2021

Vasodilatation of small and large arteries in hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2897%2970033-5

7 January 2021

Calcium antagonists as antiatherogenic agents

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2897%2970033-5

7 January 2021

Antihypertensive therapy in dialysed patients

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2897%2970033-5

7 January 2021

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2897%2970033-5

7 January 2021

Angiotensin converting enzyme inhibitors and progressive renal insufficiency. Current experience and future directions

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2897%2970033-5

7 January 2021

Medical intelligence drug therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2897%2970033-5

7 January 2021

Comparison of the effects of prazosin versus propranolol on plasma lipoprotein lipids in patients receiving hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2897%2970033-5

7 January 2021

Cardiac arrhythmias in patients on maintenance hemodialysis: causes and management

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2897%2970033-5

7 January 2021

Cardiac arrhythmias in patients on maintenance hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2897%2970033-5

7 January 2021

Cardiac arrhythmias in end-stage renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2897%2970033-5

7 January 2021

Ageing: a possible clue to the arrhythmogenic effect of hemodyalisis

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2897%2970033-5

7 January 2021

Ventricular arrhythmias in patients with hypertensive left ventricular hypertrophy

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2897%2970033-5

7 January 2021

Cardiac hypertrophy in hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2897%2970033-5

7 January 2021

Cardiac arrhythmias in hemodialysis patients. A study of incidence and contributory factors

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2897%2970033-5

7 January 2021

Dialysis-induced cardiac arrhythmias: fact or fiction? Importance of preexisting cardiac disease in the induction of arrhythmias during renal replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2897%2970033-5

7 January 2021

Hemofiltration--an improved method of treatment for chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2897%2970033-5

7 January 2021

Hemodialysis versus continuous ambulatory peritoneal dialysis: effects on the heart

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2897%2970033-5

7 January 2021

Mechanism and prevention of cardiac arrhythmias in chronic hemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2897%2970033-5

7 January 2021

Effect of digitoxin on cardiac arrhythmias in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2897%2970033-5

7 January 2021

Long-term follow-up of asymptomatic healthy subjects with frequent and complex ventricular ectopy

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2897%2970033-5

7 January 2021

The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2897%2970033-5

7 January 2021

Out-of-hospital cardiac arrest. Use of electrophysiologic testing in the prediction of long-term outcome

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2897%2970033-5

7 January 2021

High gain signal averaged electrocardiogram combined with 24 hour monitoring in patients early after myocardial infarction for bedside prediction of arrhythmic events

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2897%2970033-5

7 January 2021

Beta blockade during and after myocardial infarction: an overview of the randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2897%2970033-5

7 January 2021

Sustained ventricular tachycardia in patients with idiopathic dilated cardiomyopathy: electrophysiologic testing and lack of response to antiarrhythmic drug therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2897%2970033-5

7 January 2021

Epidemiology of symptomatic hypotension in hemodialysis: is cool dialysate beneficial for all patients?

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2897%2970033-5

7 January 2021

Alpha- and Beta-Adrenoceptor Changes in Patients on Maintenance Hemodialysis1

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2897%2970033-5

7 January 2021

Acetate and bicarbonate hemodialysis in patients with and without autonomic dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2897%2970033-5

7 January 2021

Influence of Dialysate and Membrane Biocompatibility on Hemodynamic Stability in Hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2897%2970033-5

7 January 2021

The effect of red cell transfusion on hemodialysis-related hypotension

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2897%2970033-5

7 January 2021

Paradoxical withdrawal of reflex vasoconstriction as a cause of hemodialysis-induced hypotension

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2897%2970033-5

7 January 2021

Pathophysiological Aspects of Neurocardiogenic Syncope: Current Concepts and New Perspectives

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2897%2970033-5

7 January 2021

Fluoxetine hydrochloride for the treatment of severe refractory orthostatic hypotension

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2897%2970033-5

7 January 2021

Safety of regional citrate hemodialysis in acute renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2897%2970033-5

7 January 2021

Prevention of dialysis disequilibrium syndrome by use of high sodium concentration in the dialysate

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2897%2970033-5

7 January 2021

Increased nitric oxide production in patients with hypotension during hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2897%2970033-5

7 January 2021

10.1016/S1073-4449(97)70033-5

Identifiers

DOI

0 references

1 reference